Daiwa Securities Group Inc. - IMMUNOVANT INC ownership

IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 121 filers reported holding IMMUNOVANT INC in Q4 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of IMMUNOVANT INC
ValueSharesWeighting
Q3 2023$20
+100.0%
5200.0%0.00%
Q2 2023$10
+25.0%
5200.0%0.00%
Q1 2023$8
-11.1%
5200.0%0.00%
Q4 2022$9
-99.6%
520
+32.0%
0.00%
Q3 2022$2,0000.0%3940.0%0.00%
Q2 2022$2,0000.0%3940.0%0.00%
Q1 2022$2,000
-33.3%
3940.0%0.00%
Q4 2021$3,0000.0%3940.0%0.00%
Q3 2021$3,000
+50.0%
394
+114.1%
0.00%
Q2 2021$2,000
-33.3%
1840.0%0.00%
Q1 2021$3,000
-62.5%
1840.0%0.00%
Q4 2020$8,0001840.00%
Other shareholders
IMMUNOVANT INC shareholders Q4 2021
NameSharesValueWeighting ↓
Alpine Global Management, LLC 3,000,200$26,072,0005.92%
MANGROVE PARTNERS IM, LLC 1,139,900$9,906,0000.89%
Eventide Asset Management 4,950,000$43,016,0000.57%
Ghost Tree Capital, LLC 200,000$1,738,0000.51%
WITTENBERG INVESTMENT MANAGEMENT, INC. 140,500$1,221,0000.47%
FRAZIER MANAGEMENT LLC 585,759$5,090,0000.41%
MANGROVE PARTNERS IM, LLC 500,000$4,345,0000.39%
EcoR1 Capital, LLC 1,140,819$9,914,0000.34%
BCK CAPITAL MANAGEMENT LP 53,459$465,0000.28%
PLATINUM INVESTMENT MANAGEMENT LTD 555,065$4,824,0000.14%
View complete list of IMMUNOVANT INC shareholders